China Medical & HealthCare Group Limited provided earnings guidance for the eleven months ended May 31, 2019. The board of the directors of the company expects to record a profit attributable to shareholders of the Company for the twelve months ended 30 June 2019 as compared with a loss for the corresponding twelve months period in 2018 recorded by the Group mainly due to the increase in hospital fees and charges from healthcare division; the increase in interest income from money lending business; a gain in fair value change of investments held for trading compared with a loss recorded in 2018; the decrease in finance costs; and an overall tax credit.